SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 2.7% Passive Stake in Utah Medical Products Inc.
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a passive beneficial ownership of 2.7% in Utah Medical Products Inc. as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson jointly reported beneficial ownership of 92,360 shares of Utah Medical Products Inc. common stock.
- This represents 2.7% of the total outstanding common stock of Utah Medical Products Inc.
- The filing is an Amendment No. 26 to a Schedule 13G, indicating a passive investment.
- FMR LLC holds sole voting power over 88,137 shares and sole dispositive power over 92,360 shares.
- Abigail P. Johnson holds sole dispositive power over 92,360 shares, with no sole or shared voting power.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. It's a routine filing, but the continued presence of a major institutional investor like FMR LLC, even with a passive stake, can be seen as a minor positive signal of confidence in the company.
Positives
- A significant institutional investor, FMR LLC (Fidelity), maintains a stake in Utah Medical Products Inc., potentially indicating continued confidence in the company.
- The filing confirms the investment is passive, suggesting no immediate intent to influence company control.
Negatives
- The reported ownership percentage of 2.7% is below the 5% threshold that would trigger more active reporting (Schedule 13D), indicating it is not a major new activist position.
Future Outlook
This Schedule 13G filing does not contain forward-looking statements or guidance regarding Utah Medical Products Inc.'s future performance or strategic direction.
Industry Context
This filing reflects a routine disclosure of passive institutional ownership by FMR LLC, a major asset manager, in a medical products company. It does not provide specific insights into broader industry trends or competitive landscape beyond indicating continued institutional interest in the sector.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's passive stake, which might be viewed as a vote of confidence.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting period end date). |
| 2025-01-07 | Date of filing of this Schedule 13G Amendment No. 26. |
Keywords
Utah Medical Products Inc., UMPI, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.